BRYSELDPHOENIX LTDActive

Company number 11575238Private limited companyIncorporated 2018
⚠ Accounts overdue. The next accounts were due on 30 Sep 2026 and had not been filed when the register was last updated.
⚠ Confirmation statement overdue. It was due on 1 Oct 2026.

Key figures

£227,118+16.4%
Net assets 2023/24
+43.7%
Average annual growth 2018/19–2023/24
0100 k200 k300 k2018/192019/202020/212021/222022/232023/24

Like most small UK companies, BRYSELDPHOENIX LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2023/24
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2018/192019/202020/212021/222022/232023/24
Filed accounts2018/19–2023/24
2019/202020/212021/222022/232023/24
Total assets130,483357,734404,340416,483470,990
Total liabilities42,301196,456215,605221,305243,872
Net assets / total equity88,182161,278188,735195,178227,118
Average number of employees11111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: BRYSELDPHOENIX LTD

Company

BRYSELDPHOENIX LTD is a private limited company registered with Companies House under company number 11575238. It was incorporated on 18 Sep 2018. Its status is active. The registered office is in Manchester (M2). Its nature of business (SIC 2007) is general medical practice activities (86210).

Accounts

The latest accounts in the database are for 2023/24 (period ending 30 Sep 2024); the company files micro-entity accounts. Net assets were £227,118, up 16.4% on the previous year. Total assets were £470,990 and total liabilities £243,872. The company had an average of 1 employee. Figures are available for 6 financial years (2018/19–2023/24).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Sep 2026. The next confirmation statement is due by 1 Oct 2026.